Baihua Pharmaceutical (600721.SH): Net profit in the first quarter was 20.6635 million yuan, a year-on-year increase of 209.02%

Gelonghui On April 25, Baihua Pharmaceutical (600721.SH) announced its first quarter report for 2024. During the reporting period, it achieved operating income of 90.8764 million yuan, a year-on-year increase of 20.03%. The net profit attributable to shareholders of the listed company was 20.6635 million yuan, a year-on-year increase of 209.02%. The net profit after deducting non-recurring gains and losses attributable to shareholders of listed companies was 20.1866 million yuan, a year-on-year increase of 224.24%. Basic earnings per share is 0.0541 yuan/share.

Gelonghui On April 25, Baihua Pharmaceutical (600721.SH) announced its first quarter report for 2024. During the reporting period, it achieved operating income of 90.8764 million yuan, a year-on-year increase of 20.03%.

The net profit attributable to shareholders of the listed company was 20.6635 million yuan, a year-on-year increase of 209.02%.

The net profit after deducting non-recurring gains and losses attributable to shareholders of listed companies was 20.1866 million yuan, a year-on-year increase of 224.24%.

Basic earnings per share is 0.0541 yuan/share.

Like (0)
Previous April 25, 2024 8:00 pm
Next April 25, 2024 8:00 pm

Related posts